AstraZeneca aims to double revenue to £63billion by 2030 in 'new era of growth'
The pharmaceutical giant will launch 20 new medicines over the coming years in areas like cancer care and rare diseases
The pharmaceutical giant will launch 20 new medicines over the coming years in areas like cancer care and rare diseases